Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donors

Transfusion

Volumn 43, Issue 9, 2003, Pages 1260-1268

  Pellett, Philip E ^a   Wright, D J ^b   Engels, E A ^b   Ablashi, D V ^b   Dollard, S C ^b   Forghani, B ^b   Glynn, S A ^b   Goedert, J J ^b   Jenkins, F J ^b   Lee, T H ^b   Neipel, F ^b   Todd, D S ^b   Whitby, D ^b   Nemo, G J ^b   Busch, M P ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CONTROLLED STUDY; HUMAN; HUMAN HERPESVIRUS 8; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MASS SCREENING; POLYMERASE CHAIN REACTION; SEROLOGY; SEROPREVALENCE; UNITED STATES; VIREMIA; VIRUS TRANSMISSION;

ANTIBODIES, VIRAL; BLOOD BANKS; BLOOD DONORS; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HUMANS; REFERENCE STANDARDS; SENSITIVITY AND SPECIFICITY; SEROEPIDEMIOLOGIC STUDIES; UNITED STATES;

EID: 0042835807     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2003.00490.x     Document Type: Article

References (41)

1. Schulz TF. Epidemiology of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8. Adv Cancer Res 1999;76:121-60.
2. Whitby D, Howard MR, Tenant-Flowers M, et al. Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet 1995;346:799-802.
3. Blackbourn DJ, Ambroziak J, Lennette E, et al. Infectious human herpesvirus 8 in a healthy North American blood donor. Lancet 1997;349:609-11.
4. Parravicini C, Olsen SJ, Capra M, et al. Risk of Kaposi's sarcoma-associated herpes virus transmission from donor aflografts among Italian posttransplant Kaposi's sarcoma patients. Blood 1997;90:2826-9.
5. Luppi M, Barozzi P, Santagostino G, et al. Molecular evidence of organ-related transmission of kaposi sarcoma-associated herpesvirus or human herpesvirus-8 in transplant patients. Blood 2000;96:3279-81.
6. Cannon MJ, Dollard SC, Smith DK, et al. Blood-borne and sexual transmission of human herpesvirus 8 in women with or at risk for human immunodeficiency virus infection. N Engl J Med 2001;344:637-43.
7. Belec L, Cancre N, Hallouin MC, et al. High prevalence in Central Africa ofblood donors who are potentially infectious for human herpesvirus 8. Transfusion 1998;38:771-5.
8. Beral V, Peterman TA, Berkelman RL, Jaffe HW. Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? Lancet 1990;335:123-8.
9. Gao SJ, Kingsley L, Li M, et al. KSHV antibodies among Americans, Italians and Ugandans with and witho ut Kaposi's sarcoma. Nat Med 1996;2:925-8.
10. Lennette ET, Blackbourn DJ, Levy JA. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients. Lancet 1996;348:858-61.
11. Simpson GR, Schulz TF, Whitby D, et al. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 1996;348:1133-8.
12. Engels EA, Eastman H, Ablashi DV, et al. Risk of transfusion-associated transmission of human herpesvirus 8. J Natl Cancer Inst 1999;91:1773-5.
13. Operskalski EA, Busch MP, Mosley JW, Kedes DH. Blood donations and viruses. Lancet 1997;349:1327.
14. Manns A, Wilks RJ, Murphy EL, et al. A prospective study of transmission by transfusion of HTLV-1 and risk factors associated with seroconversion. Int J Cancer 1992;51:886-91.
15. Busch M, Chamberland M, Epstein J, et al. Oversight and monitoring of blood safety in the United States. Vox Sang 1999;77:67-76.
16. Rabkin CS, Schulz TF, Whitby D, et al. Interassay correlation of human herpesvirus 8 serologic tests. HHV-8 Inter-laboratory Collaborative Group. J Infect Dis 1998;178:304-9.
17. Enbom M, Sheldon J, Lennette E, et al. Antibodies to human herpesvirus 8 latent and lytic antigens in blood donors and potential high-risk groups in Sweden: variable frequencies found in a multicenter serological study. J Med Virol 2000;62:498-504.
18. Schatz O, Monini P, Bugarini R, et al. Kaposi's sarcoma-associated herpesvirus serology in Europe and Uganda: multicentre study with multiple and novel assays. J Med Virol 2001;65:123-32.
19. Walter SD, Irwig LM. Estimation of test error rates, disease prevalence and relative risk from misclassified data: a review. J Clin Epidemiol 1988;41:923-37.
20. Engels EA, Sinclair MD, Biggar RJ, et al. Latent class analysis of human herpesvirus 8 assay performance and infection prevalence in sub-Saharan Africa and Malta. Int J Cancer 2000;88:1003-8.
21. Zuck TF, Thomson RA, Schreiber GB, et al. The Retrovirus Epidemiology Donor Study (REDS): rationale and methods. Transfusion 1995;35:944-51.
22. Pau CP, Lam LL, Spira TJ, et al. Mapping and serodiagnostic application of a dominant epitope within the human herpesvirus 8 ORF 65-encoded protein. J Clin Microbiol 1998;36:1574-7.
23. Spira TI, Lam L, Dollard SC, et al. Comparison of serologic assays and PCR for diagnosis of human herpesvirus 8 infection. J Clin Microbiol 2000;38:2174-80.
24. Martin JN, Amad Z, Cossen C, et al. Use of epidemiologically well-defined subjects and existing immunofluorescence assays to calibrate a new enzyme immunoassay for human herpesvirus 8 antibodies. J Clin Microbiol 2000;38:696-701.
25. Forghani B, Myoraku CK, Schmidt NJ. Production of monoclonal antibodies to human IgM for assay of viral antibodies. J Virol Methods 1982;5:317-27.
26. Engels EA, Whitby D, Goebel PB, et al. Identifying human herpesvirus 8 infection: performance characteristics of serologic assays. J Acquir Immune Defic Syndr 2000;23:346-54.
27. Chatlynne LG, Lapps W, Handy M, et al. Detection and titration of human herpesvirus-8-specific antibodies in sera from blood donors, acquired immunodeficiency syndrome patients, and Kaposi's sarcoma patients using a whole virus enzyme-linked immunosorbent assay. Blood 1998;92:53-8.
28. Ablashi D, Chatlynne L, Cooper H, et al. Seroprevalence of human herpesvirus 8 (HHV-8) in countries of Southeast Asia compared to USA, the Caribbean and Africa. Br J Cancer 1999;81:893-7.
29. Renne R, Zhong W, Herndier B, et al. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat Med 1996;2:342-6.
30. Lang D, Hinderer W, Rothe M, et al. Comparison of the immunoglobulin-G-specific seroreactivity of different recombinant antigens of the human herpesvirus 8. Virology 1999;260:47-54.
31. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994;266:1865-9.
32. Rindskopf D, Rindskopf W. The value of latent class analysis in medical diagnosis. Stat Med 1986;5:21-7.
33. Yang I, Becker MP. Latent variable modeling of diagnostic accuracy. Biometrics 1997;53:948-58.
34. Espeland MA, Handelman SL. Using latent class models to characterize and assess relative error in discrete measurements. Biometrics 1989;45:587-99.
35. Meng XL, Rubin DB. Maximum likelihood estimation via the ECM algorithm: a general framework. Biomerika 1993;80:267-78.
36. Miller RG. Survival analysis, New York: Wiley; 1981.
37. Fliess JL. The measurement of interrater agreement. In: Statistical methods for rates and proportions. New York: Wiley; 1981:212-36.
38. Hoehler F. Bias and prevalence effects on kappa viewed in terms of sensitivity and specificity. J Clin Epidemiol 2000;53:499-503.
39. Faraone SV, Tsuang MT. Measuring diagnostic accuracy in the absence of a "gold standard." Am J Psychiatry 1994;151:650-7.
40. Hladik W, Dollard SC, Downing RG, et al. Kaposi's sarcoma in Uganda: risk factors for human herpesvirus 8 infection among blood donors. J Acquir Immune Defic Syndr 2003;33:206-10.
41. Hudnall SD, Chen T, Rady P, et al. Human herpesvirus 8 seroprevalence and viral load in healthy adult blood donors. Transfusion 2003;43:85-90.